US Stock MarketDetailed Quotes

NAVB Navidea Biopharmaceuticals

Watchlist
  • 0.038
  • +0.003+9.29%
15min DelayClose May 3 16:00 ET
3.83MMarket Cap-478P/E (TTM)

Navidea Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2022/FY
Stock NameRevenueRatio
Diagnostics65.65K100.00%
Region Currency:USD
2022/FY
Stock NameRevenueRatio
Grant and other revenue51.01K77.69%
Europe14.04K21.38%
Australia6100.93%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg